Pipeline

|
Press Releases
2010-01-14
Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
2010-01-06
Dr. Marco Gambacciani, M.D. Joins Bionovo, Inc. Medical Advisory Board
2009-12-29
Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer
2009-11-05
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
|
Events
No upcoming investor events
See recent company presentations and webcasts
|